The Flow Cytometry Services Market Size is valued at 912.13 Million in 2023 and is predicted to reach 1615.16 Million by the year 2031 at a 7.56% CAGR during the forecast period for 2024-2031.
Key Industry Insights & Findings from the Report:
- This market growth is being attributed to the increasing prevalence of HIV/AIDS and cancer, as well as new technological advancements in flow cytometry instruments.
- The growing uses of flow cytometry in research fuel the market’s demand for the technology.
- North America dominated the market and accounted for a global revenue share in 2023.
- The high cost of instruments is expected to impede the market's growth.
In the flow cytometry technique, cells pass in a single file before a laser to be detected, counted, and sorted. Cells are inserted into a fluid medium that passes through a laser beam. The emission by the cell scatters in different directions towards receptors that capture the light and display translated data on a monitor. This technique can analyze thousands of particles per second. The method allows qualitative and quantitative analysis of several properties of the cell populations. Cell cytometry provides rapid, accurate and high output cell analysis and has been applied to observe diverse biological processes like cell cycle, cell proliferation, cell viability, cell phenotyping, cell signalling, micronucleus test, intracellular cytokine secretion. Flow cytometry services consist of specimen processing, experimental design, acquisition and data analysis to strengthen biotech, pharmaceutical companies and researchers in drug development. The flow cytometry market contains instruments, software and chemicals and related services.
The gradual increase in HIV/AIDS and cancer cases globally is a significant driver for the flow cytometry market. The flow cytometry technique has its direct application in HIV diagnosis, and hence the demand for diagnosis techniques like flow cytometry is also growing. The availability of ELISA (enzyme-linked Immunosorbent Assay) and radioimmunoassay as low-cost substitutes are responsible for inhibiting the flow cytometry market.
Market Segmentation
The Global Flow cytometry services market is segmented based on the accreditation types, services and region. The types of accreditation consist of government and third-party accreditation. By the service types, the market is classified into general flow cytometric service, including assay development and consumables manufacturing. Secondly, analysis based flow cytometric services include PBMC analysis, whole blood cells analysis, bone marrow aspirate analysis, stem cells analysis, rare cells detection, cell profiling and subsetting, intracellular staining. This service type also includes other types of flow cytometric services. Region-wise, market is studied across North America, Europe, Asia-Pacific, Latin America, middle east and Africa
Competitive Landscape
Some Of The Key Players In The Flow Cytometry Services Market:
- FlowMetric Life Sciences,
- Flow Contract Sites Laboratory,
- Bio-Legend,
- Q2 Solutions,
- ProImmune,
- MLM Medical Labs,
- Unilabs,
- Firalis,
- Agilex Biolabs,
- ACROBIOsystems,
- Ardena,
- Life Science Research,
- Cell flow cytometry,
- Research Lab Services,
- Fluorescence,
- CHOP Research Institute,
- Bio-Rad Laboratories,
- Plant Cytometry services,
- Aurelia Bioscience,
- Proimmune,
- Sphere Fluidics Limited,
- Icon plc,
- Beakman Coulter,
- IBR Inc.,
- FACS Servies,
- Flow Contract side Laboratory,
- Rockland-inc,
- NeoGenomics,
- Charles River Laboratories,
- ProMab,
- RayBiotech,
- Creative Proteomics,
- ACM Global Laboratories,
- Covance,
- ReachBio,
- Mdbiosciences,
- CSI Laboratories,
- Other Prominent Players.
The Flow Cytometry Services Market Report Scope
|
Report Attribute |
Specifications |
|
Market Size Value In 2023 |
USD 912.13 Million |
|
Revenue Forecast In 2031 |
USD 1615.16 Million |
|
Growth Rate CAGR |
CAGR of 7.56% from 2024 to 2031 |
|
Quantitative Units |
Representation of revenue in US$ Billion and CAGR from 2024 to 2031 |
|
Historic Year |
2019 to 2023 |
|
Forecast Year |
2024-2031 |
|
Report Coverage |
The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
|
Segments Covered |
By Accreditation Type, By Service Type |
|
Regional Scope |
North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
|
Country Scope |
U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico ;The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
|
Competitive Landscape |
FlowMetric Life Sciences, Flow Contract Sites Laboratory, Bio-Legend, Q2 Solutions, ProImmune, MLM Medical Labs, Unilabs, Firalis, Agilex Biolabs, ACROBIOsystems, Ardena, Life Science Research, Cell flow cytometry, Research Lab Services, Fluorescence, CHOP Research Institute, Bio-Rad Laboratories, Plant Cytometry services, Aurelia Bioscience, Proimmune, Sphere Fluidics Limited, Iconplc, Beakman Coulter, IBR Inc., FACS Servies, Flow Contract side Laboratory, Rockland-inc, NeoGenomics, Charles River Laboratories, ProMab, RayBiotech, Creative Proteomics, ACM Global Laboratories, Covance, ReachBio, Mdbiosciences, CSI Laboratories, Other Prominent Players. |
|
Customization Scope |
Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape. |
|
Pricing And Available Payment Methods |
Explore pricing alternatives that are customized to your particular study requirements. |
Corporate
Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
info@insightaceanalytic.com
